Core Points - The company is holding its second extraordinary general meeting of shareholders in 2025 to discuss various proposals related to corporate governance and board elections [1][9][11] Meeting Procedures - The company has established guidelines for the meeting to ensure order and efficiency, including identity verification for attendees and a requirement for prior registration [2][4] - Attendees must arrive at least 30 minutes before the meeting to complete registration and present necessary documentation [2][3] - Voting will be conducted through a combination of on-site and online methods, with specific time frames for each [4][6] Agenda Items - The meeting will address several key proposals, including the cancellation of the supervisory board and amendments to the company's articles of association [9][10] - The company plans to elect a new board of directors, with nominations for both non-independent and independent directors [11][13] - The election will utilize a cumulative voting system, allowing shareholders to vote on multiple candidates simultaneously [12][14] Governance Improvements - The company aims to enhance its governance structure in line with recent legal and regulatory changes, including the implementation of new company laws and guidelines [10][11] - Specific internal governance policies are proposed for revision to align with the updated articles of association [10]
和元生物: 2025年第二次临时股东大会会议资料